| Literature DB >> 32526086 |
Sanne Vogels1,2, Ewan D Ritchie1,2, Thijs T C F van Dongen1,3, Marc R M Scheltinga4, Wes O Zimmermann5,6, Rigo Hoencamp1,2,3,7.
Abstract
OBJECTIVE: Surgery is the gold standard in the management of chronic exertional compartment syndrome (CECS) of the lower extremity, although recent studies also reported success following gait retraining. Outcome parameters are diverse, and reporting is not standardized. The aim of this systematic review was to analyze the current evidence regarding treatment outcome of CECS in the lower leg.Entities:
Keywords: chronic exertional compartment syndrome; conservative treatment; fasciotomy; lower extremity; systematic review
Mesh:
Substances:
Year: 2020 PMID: 32526086 PMCID: PMC7540008 DOI: 10.1111/sms.13747
Source DB: PubMed Journal: Scand J Med Sci Sports ISSN: 0905-7188 Impact factor: 4.221
FIGURE 1Flow chart of selected studies.
CECS study characteristics (n =; 68)
| Author | Design | Level of Evidence | patients (n) | Patient population? | Male/Female | µ age in year (min‐max) | Affected compartments | µ duration symptoms in months (min‐max) | n conservative patients/ n surgical patients | Conservative Intervention(s) | Surgical approach | µ Follow‐up in months (min‐max) | Outcome measurements used | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICP | Patient satisfaction | Return to activity | SANE | LLOS | Complications (in %) | Recurrence (in %) | Reoperations (in %) | |||||||||||||
| Akermark et al | R | 4 | 30 | C | 19/11 | 23 (15‐36) | DP | ‐ | ‐/30 | ‐ | Open | 34 (6‐85) | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| Ali et al | P | 4 | 20 | ‐ | ‐ | ‐ | A | ‐ | 4/16 | PT | ES | 6 (‐) | N | Y | N | N | N | 0 | ‐ | ‐ |
| Allen & Barnes | P | 4 | 110 | C | 86/24 | ‐ (12‐44) | A, DP | ‐ | ‐/110 | ‐ | MI | ‐ | Y | N | Y | N | N | 0 | 1 | ‐ |
| Balius et al | P | 4 | 7 | C | ‐ | 26 (18‐34) | A | ‐ | ‐/7 | ‐ | MI | 25 (12‐38) | N | N | Y | N | N | ‐ | ‐ | ‐ |
| Beck et al | R | 4 | 135 | C | ‐ | ‐ | A, L, DP, SP | ‐ | ‐/135 | ‐ | Open, MI & ES | 11 (6‐28) | N | N | Y | N | N | 11.2 | ‐ | 19 |
| Biedert & Marti | R | 4 | 15 | C | 14/1 | 29 (‐) | DP | 54 (12‐180) | ‐/15 | ‐ | Open | 27 (8‐72) | Y | N | N | N | N | ‐ | ‐ | ‐ |
| Blackman et al | P | 4 | 7 | C | 6/1 | 25 (21‐29) | A | ‐ | 7/‐ | M | ‐ | 1 (‐) | Y | N | N | N | N | ‐ | ‐ | ‐ |
| Breen et al | P | 4 | 10 | C | 9/1 | 31 (‐) | ‐ | ‐ | 10/‐ | GR | ‐ | 12 (‐) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Cook & Bruce | R | 4 | 14 | M | 10/4 | 27 (22‐38) | A, L, DP, SP | 63 (6‐120) | ‐/14 | ‐ | Open | 37 (11‐90) | N | Y | N | N | N | 11.1 | 3.7 | 3.7 |
| de Bruijn et al | P | 4 | 14 | C | 5/9 | 26 (18‐48) | A | ‐ (6‐240) | ‐/14 | ‐ | MI | 21 (16‐25) | N | Y | Y | N | N | 3.6 | ‐ | ‐ |
| de Fijter et al | R | 4 | 72 | C + M | 65/7 | 21 (18‐37) | A | ‐ | ‐/72 | ‐ | MI | 62 (‐) | N | N | Y | N | N | 18 | 2 | 2 |
| Detmer et al | R | 4 | 100 | C | 51/49 | 26 (‐) | A, L, DP, SP | 22 (‐) | ‐/100 | ‐ | Open & MI | 5 (0‐47) | N | Y | Y | N | N | 7.7 | 3.4 | 3.4 |
| Diebal et al | P | 4 | 10 | M | 8/2 | 20 (‐) | A, L | ‐ | 10/‐ | GR | ‐ | 12 (‐) | Y | N | Y | Y | Y | ‐ | ‐ | ‐ |
| Drexler et al | R | 4 | 53 | C | 49/4 | 24 (16‐43) | A, L | 22 (1‐120) | ‐/53 | ‐ | MI | 50 (5‐98) | N | Y | N | N | N | 16.8 | 8.4 | ‐ |
| Edmundsson et al | P | 4 | 18 | C | 8/10 | 36 (16‐65) | ‐ | 31 (6‐180) | ‐/18 | ‐ | Open | 12 (‐) | N | Y | N | N | N | 10.5 | ‐ | ‐ |
| Finestone et al | R | 4 | 36 | C + M | ‐ | 24 (16‐54) | A | ‐ | ‐/36 | ‐ | ‐ | 116 (‐) | N | N | N | N | N | 4.9 | ‐ | 1.6 |
| Fronek et al | R | 4 | 18 | C | 8/10 | 24 (12‐43) | A, L | ‐ | 5/13 | AM | Open | 50 (‐) | Y | Y | Y | N | N | 10 | ‐ | 5 |
| Garcia‐Mata et al | R | 4 | 23 | C | 10/13 | 16 (14‐18) | A, L, DP, SP | 24 (7‐72) | ‐/23 | ‐ | Open | 58 (12‐84) | Y | Y | Y | N | N | 2.3 | 0 | 2.3 |
| Gatenby et al | R | 4 | 20 | C | 8/12 | 28 (16‐50) | A, L | 32 (1‐131) | ‐/20 | ‐ | Open | ‐ | N | N | Y | N | N | 5.6 | 5.6 | 2.8 |
| Helmhout et al | P | 3 | 19 | M | 18/1 | 25 (19‐53) | ‐ | ‐ | 19/‐ | GR | ‐ | 4 (‐) | Y | N | N | Y | Y | ‐ | ‐ | ‐ |
| Helmhout et al | P | 4 | 6 | M | 6/0 | 21 (18‐27) | ‐ | ‐ (6‐36) | 6/‐ | GR | ‐ | 9 (‐) | N | N | N | Y | Y | ‐ | ‐ | ‐ |
| Howard et al | R | 4 | 39 | C | 14/25 | 32 (‐) | A, L, DP, SP | ‐ | ‐/39 | ‐ | Open | 185 (‐) | N | Y | Y | N | N | 13 | ‐ | 6 |
| Irion et al | R | 4 | 13 | C | 6/7 | 20 (17‐24) | A, L, DP, SP | ‐ (0‐4) | ‐/13 | ‐ | Open | 11 (2‐60) | N | N | Y | N | N | 7.7 | 31 | 7.7 |
| Islam & Robbs. | P | 3 | 120 | C | 86/34 | 28 (18‐53) | A, L, DP, SP | 42 (12‐72) | ‐/120 | ‐ | Open | 12 (‐) | N | Y | N | N | N | 11 | 0.5 | 0.5 |
| Isner‐Horobeti et al | R | 4 | 16 | C + M | 13/3 | 23 (18‐36) | A, L | 40 (4‐240) | ‐/16 | BI | ‐ | 4 (3‐9) | Y | Y | Y | N | N | ‐ | ‐ | ‐ |
| Jarvinnen et al | R | 4 | 34 | C | 26/8 | 24 (15‐41) | DP | 18 (3‐60) | ‐/34 | ‐ | Open | ‐ (12‐120) | N | Y | N | N | N | 9 | 6 | 6 |
| Lohrer & Nauck. | R | 4 | 17 | C | 8/9 | 24 (14‐43) | A, L, DP | 38 (6‐360) | ‐/17 | ‐ | ES | 47 (5‐84) | N | Y | Y | N | N | 10.5 | 0 | 5.3 |
| Maffulli et al | P | 4 | 18 | C | 12/6 | 27 (18‐35) | A, L | 17 (5‐31) | ‐/18 | ‐ | MI | 8 (5‐12) | N | Y | Y | N | N | 14.8 | 0 | ‐ |
| Maher et al | R | 4 | 21 | C | 5/16 | 25 (‐) | ‐ | 15 (‐) | ‐/21 | ‐ | Open | 213(32‐329) | N | N | Y | N | N | ‐ | ‐ | ‐ |
| McCallum et al | R | 4 | 46 | M | 38/8 | 30 (19‐50) | A, L, DP, SP | ‐ | ‐/46 | ‐ | ‐ | 26 (8‐51) | N | Y | Y | Y | N | 20 | ‐ | 1.4 |
| Micheli et al | R | 4 | 47 | C | ‐ | 17 (14‐21) | A, L, DP, SP | 15 (‐) | ‐/47 | ‐ | MI | 50 (3‐162) | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| Moeyersoons et al | R | 4 | 100 | C | 81/19 | 14 (‐) | ‐ | 24 (‐) | ‐/100 | ‐ | Open | ‐ | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| Mouhsine et al | R | 4 | 18 | C | 10/8 | 25 (19‐38) | A, L | ‐ | ‐/18 | ‐ | Open | 24 (‐) | N | N | Y | N | N | 0 | 0 | 0 |
| Orlin et al | R | 4 | 37 | C | 17/20 | 37 (‐) | A, L, DP, SP | ‐ | ‐/37 | ‐ | Open | 34 (24‐52) | N | Y | N | N | N | 2.7 | ‐ | ‐ |
| Packer et al | R | 3 | 100 | C | 32/68 | 26 (‐) | ‐ | ‐ | 27/73 | AM | ‐ | 67 (‐) | N | Y | Y | N | N | 6.4 | ‐ | ‐ |
| Pandya & Ganley. | R | 4 | 6 | C | ‐ | ‐ (15‐17) | A, L | ‐ | ‐/6 | ‐ | ES | ‐ | N | N | Y | N | N | 9.1 | ‐ | 0 |
| Pasic et al | R | 4 | 46 | C | 23/23 | 30 (16‐57) | A, L, DP, SP | 48 (0‐252) | ‐/46 | ‐ | Open | 55 (4‐127) | N | Y | Y | N | N | ‐ | ‐ | 11 |
| Puranen & Alavaikko. | R | 4 | 24 | C | 11/13 | 29 (16‐63) | A, DP | ‐ | ‐/24 | ‐ | ‐ | ‐ (2‐8) | Y | N | N | N | N | ‐ | ‐ | ‐ |
| Qvarfordt et al | R | 4 | 15 | C | 8/7 | 29 (17‐50) | A, L | 36 (5‐108) | ‐/15 | ‐ | Open | 3 (‐) | Y | Y | N | N | N | ‐ | ‐ | ‐ |
| Raikin et al | R | 4 | 16 | C | 6/10 | 25 (14‐50) | A, L, DP | 30 (7‐72) | ‐/16 | ‐ | Open | 16 (6‐48) | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| Reneman. | R | 4 | 61 | C + M | 58/3 | 21 (18‐57) | A, L | ‐ | ‐/61 | ‐ | Open | ‐ (2‐48) | Y | N | Y | N | N | ‐ | ‐ | ‐ |
| Rettig et al | R | 4 | 12 | C | 1/11 | 21 (15‐30) | A, L, DP | 17 (1‐36) | ‐/12 | ‐ | ‐ | ‐ (6‐24) | N | Y | Y | N | N | 4.8 | ‐ | ‐ |
| Roberts et al | R | 4 | 98 | M | 88/10 | 28 (‐) | A | ‐ | ‐/98 | ‐ | Open | 23 (‐) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Rorabeck et al | R | 4 | 12 | C | 9/3 | 21 (18‐26) | A, L, DP, SP | 11 (5‐18) | ‐/12 | ‐ | Open | 12 (6‐24) | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| Rorabeck et al | R | 4 | 25 | C | 14/11 | 22 (‐) | A, L, DP | ‐ (12‐84) | ‐/25 | ‐ | Open | ‐ (24‐42) | N | Y | Y | N | N | 4 | 12 | 8 |
| Schepsis et al | P | 4 | 20 | C | 8/12 | 23 (16‐37) | A, L | ‐ (4‐30) | ‐/20 | ‐ | Open | 26 (12‐42) | N | Y | N | N | N | 3.3 | ‐ | ‐ |
| Schepsis et al | R | 4 | 28 | C | 15/13 | ‐ (15‐39) | A, L, DP | ‐ (2‐30) | ‐/28 | ‐ | Open | 50 (‐) | N | Y | N | N | N | 8.7 | ‐ | 2.2 |
| Sebik & Dogan. | P | 4 | 6 | C | 4/2 | 28 (‐) | A | ‐ | ‐/6 | ‐ | ES | 24 (‐) | N | Y | Y | N | N | 0 | ‐ | ‐ |
| Simpson et al | R | 4 | 41 | M | ‐ | ‐ | A | 40 (9‐110) | ‐/41 | ‐ | MI | ‐ | N | N | Y | N | N | ‐ | ‐ | ‐ |
| Singh et al | R | 4 | 15 | C + M | 13/2 | 31 (20‐43) | A, L, DP, SP | ‐ | ‐/15 | ‐ | Open | 3 (1‐6) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Slimmon et al | R | 3 | 62 | C | 27/35 | 26 (‐) | ‐ | 30 (2‐300) | ‐/62 | ‐ | Open | 51 (24‐107) | N | Y | Y | N | N | 3.4 | 11 | 11 |
| Styf & Korner. | R | 4 | 19 | C | 14/5 | 26 (17‐51) | A | 30 (10‐84) | ‐/19 | ‐ | Open | 25 (19‐46) | N | Y | Y | N | N | ‐ | 6.7 | 6.7 |
| Sudmann. | R | 4 | 29 | C + M | 11/18 | ‐ (14‐70) | A | ‐ (1‐120) | ‐/29 | ‐ | MI | ‐ (8‐30) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Takebayashi et al | R | 4 | 9 | C | 6/3 | 22 (18‐24) | A, L, DP, SP | ‐ | ‐/9 | ‐ | ‐ | ‐ | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Thein et al | R | 4 | 55 | C | 36/7 | 24 (‐) | A | ‐ | 12/43 | AM | Open | 28 (‐) | N | N | Y | N | N | 7.4 | ‐ | ‐ |
| Turnipseed. | R | 4 | 796 | C | 279/517 | ‐ | A, L, DP, SP | ‐ | ‐/796 | ‐ | Open & MI | ‐ | N | Y | N | N | N | 7 | 3.9 | ‐ |
| van den Brand et al | P | 3 | 10 | C + M | 8/2 | 23 (‐) | A | ‐ | ‐/10 | ‐ | MI | ‐ | Y | N | N | N | N | ‐ | ‐ | ‐ |
| van den Brand et al | P | 3 | 42 | M | ‐ | ‐ | A | ‐ | ‐/42 | ‐ | MI | ‐ | Y | N | N | N | N | ‐ | ‐ | ‐ |
| van der Wal et al | R | 4 | 12 | M | 11/1 | 30 (‐) | A | 50 (‐) | 12/6 | LM | MI | 2 (‐) | Y | Y | N | N | N | 0 | ‐ | ‐ |
| van Zantvoort et al | R | 4 | 30 | C | 14/16 | 29 (17‐65) | A, L, DP, SP | ‐ | ‐/30 | ‐ | Open | ‐ (12‐108) | N | Y | Y | N | N | ‐ | ‐ | ‐ |
| van Zoest et al | R | 4 | 46 | C | 19/27 | 35 (‐) | DP | ‐ | 19/27 | LM | Open | 36 (19‐44) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Verleisdonk et al | P | 4 | 53 | C + M | 47/6 | ‐ (18‐41) | A | 24 (‐) | 3/50 | AM | MI | ‐ | Y | Y | N | N | N | ‐ | 5.7 | 1.4 |
| Verleisdonk et al | R | 4 | 81 | C + M | 77/4 | 24 (18‐54) | A, L | 6 (1‐60) | ‐/81 | ‐ | MI | 6 (‐) | Y | Y | Y | N | N | 2.6 | ‐ | ‐ |
| Waterman et al | R | 4 | 611 | M | 561/50 | 28 (‐) | A, L, DP, SP | ‐ | ‐/611 | ‐ | Open | ‐ | N | N | Y | N | N | 14.3 | 45 | 5.9 |
| Winkes et al | P | 4 | 52 | C | 23/29 | 33 (‐) | A, L, DP | ‐ | ‐/52 | ‐ | Open | 39 (3‐89) | N | Y | N | N | N | ‐ | ‐ | ‐ |
| Winkes et al | P | 4 | 42 | C | 23/19 | ‐ (17‐52) | DP | ‐ (3‐72) | ‐/42 | ‐ | Open | 26 (12‐42) | N | Y | Y | N | N | 6.3 | 6.2 | 1.6 |
| Wittstein et al | R | 4 | 9 | C | 4/5 | 24 (13‐54) | A, L, DP, SP | ‐ | ‐/9 | ‐ | ES | 45 (5‐90) | N | N | Y | N | N | 14.3 | 0 | 0 |
| Zimmermann et al | R | 3 | 37 | M | 32/5 | 23 (19‐30) | A | 11 (3‐28) | 37/‐ | GR | ‐ | 11 (3‐28) | N | Y | N | Y | N | ‐ | ‐ | ‐ |
Abbreviations: ‐, information not available; A, anterior compartment; AM, Activity modification; BI, botulinum injection; C, civil population; DP, deep posterior compartment; ES, endoscopic; GR, Gait retraining; L, lateral compartment; LM, Lifestyle modification; M, military population; MI, minimally invasive; N, no; P, prospective; PT, Physical therapy; R, retrospective; SP, superficial posterior compartment; Y, yes.
Treatment outcome following conservative intervention in CECS
| n | Conservative Intervention | ICP values | SANE | LLOS | Satisfaction (in %) | Return to activity (in %) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measurement | Before intervention µ in mm Hg (±SD) | After intervention µ in mm Hg (±SD) | Change (P‐value) | Before intervention (±SD) | After intervention (±SD) | Change (P‐value) | Before intervention (±SD) | After intervention (±SD) | Change (P‐value) | Satisfied or improved | Very satisfied or symptom free | Previous level | Full activity | |||
| Ali et al | 4 | PT | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 0 | ‐ | ‐ | ‐ |
| Blackman et al | 7 | M | 3‐min PE | 63 (±21) | 68 (±24) | 0.156 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Breen et al | 10 | GR | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 17 | 83 | ‐ | ‐ |
| Diebal et al | 10 | GR |
Resting 1‐min PE |
40 (±11) 78 (±32) |
36 (±12) 38 (±12) |
‐ 0.002 | 50 (±21) | 90 (±10) | <0.01 | 67.3 (±13.7) | 91.5 (±8.5) | <0.01 | ‐ | ‐ | 100 | ‐ |
| Fronek et al | 5 | AM | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 20 | ‐ | 0 | ‐ |
| Helmhout et al | 19 | GR | 1‐min PE | 73 (‐) | 47 (‐) | <0.05 | 56 (±15) | 77 (±22) | 0.00 | 72.0 (±11.3) | 84.6 (±15.5) | 0.00 | ‐ | ‐ | ‐ | ‐ |
| Isner‐Horobeti et al | 16 | BI |
anterior 1‐min PE 5‐min PE lateral 1‐min PE 5‐min PE |
65 (‐) 40 (‐) 60 (‐) 39 (‐) |
22 (‐) 12 (‐) 19 (‐) 10 (‐) |
<0.0001 <0.0001 <0.001 <0.01 | 94 | 94 | ||||||||
| Packer et al | 27 | AM | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 56 | ‐ | ‐ | 30 |
| Thein et al | 12 | AM | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 25 | ‐ |
| van der Wal et al | 12 | LM | PE | 58 (±15) | 51 (±15) | NS | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 0 | ‐ | ‐ | ‐ |
| Van Zoest et al | 19 | LM | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 84 | ‐ | ‐ | ‐ |
| Verleisdonk et al | 3 | AM | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 0 | ‐ | ‐ | ‐ |
| Zimmermann et al | 37 | GR | ‐ | ‐ | ‐ | ‐ | 51 (±15) | 73 (±22) | <0.01 | ‐ | ‐ | ‐ | 70 | 19 | ‐ | ‐ |
Abbreviations: ‐, information not available; AM, Activity modification; BI, botulinum injection; GR, Gait retraining; ICP, intracompartmental pressure; LLOS, Lower Leg Outcome Survey (0‐60, with 60 being normal); LM, Lifestyle modification; M, Massage; PE, post‐exercise; PT, Physical therapy; SANE, Single Assessment Numeric Evaluation (0‐100 scale, with 100 being normal).
Treatment outcome following surgical intervention for CECS
| Legs (n) | Compartments (n) | Type of Surgery | ICP in mm Hg | Likert Scale (in %) | Satisfaction (in %) | Return to activity (in %) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measurement | Before intervention µ (±SD) | After intervention µ (±SD) | Change (P‐value) | Excellent | Good | Fair | Poor | Bad | Satisfied/ improved | Very satisfied/ symptom free | Previous level | Full activity | ||||
| Akermark et al | 60 | 60 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 30 | 57 | ‐ | 67 |
| Ali et al | 24 | 24 | ES | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ | ‐ |
| Allen & Barnes | 73 | 84 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 96 |
| Balius et al | 9 | 9 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 86 | ‐ |
| Beck et al | 250 | 741 | Open, MI & ES | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 80 | ‐ |
| Biedert & Marti. | 15 | ‐ | Open |
Rest PE |
6 (‐) 19 (‐) |
2 (‐) 2 (‐) |
<0.005 <0.0001 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Cook & Bruce | 27 | 56 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | 78.5 | ‐ | ‐ | |||||
| de Bruijn et al | 28 | 28 | MI | ‐ | ‐ | ‐ | ‐ | 31 | 31 | 23 | 8 | 8 | ‐ | ‐ | 100 | ‐ |
| de Fijter et al | 118 | 118 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 94 |
| Detmer et al | ‐ | 233 | Open & MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 9 | 73 | 16 | 75 |
| Drexler et al | 95 | 95 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 75.5 | ‐ | ‐ | ‐ |
| Edmundsson et al | 57 | 121 | Open | ‐ | ‐ | ‐ | ‐ | 11 | 61 | 26 | 2 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Fronek et al | 20 | 40 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 94 | 94 | ‐ |
| Garcia‐Mata et al | 43 | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ | 100 |
| Gatenby et al | 36 | 72 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 50 | 40 |
| Howard et al | 39 | 78 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 79 | ‐ | 78 | ‐ |
| Irion et al | 20 | 48 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 85 | ‐ |
| Islam & Robbs. | 216 | 376 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 6 | 90 | ‐ | ‐ |
| Jarvinnen et al | 34 | 48 | Open | ‐ | ‐ | ‐ | ‐ | 41 | 37 | 15 | 7 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Lohrer & Nauck | 38 | 38 | ES | ‐ | ‐ | ‐ | ‐ | 53 | 6 | 24 | 18 | ‐ | ‐ | 59 | 82 | ‐ |
| Maffulli et al | 27 | 38 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | 94 | ‐ | ‐ | ‐ | ‐ | ‐ | 83 | 11 |
| Maher et al | 36 | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 75 | ‐ |
| McCallum et al | 70 | 114 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 71.4 | ‐ | 37 | 41 |
| Micheli et al | 72 | 103 | MI | ‐ | ‐ | ‐ | ‐ | 47 | 28 | 15 | 9 | ‐ | ‐ | ‐ | 75 | ‐ |
| Moeyersoons & Martens | 85 | ‐ | Open | ‐ | ‐ | ‐ | ‐ | 75 | 6 | 19 | ‐ | ‐ | ‐ | 83.5 | 84 | ‐ |
| Mouhsine et al | 29 | 36 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ |
| Orlin et al | 74 | 296 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 30 | 63 | ‐ | ‐ |
| Packer et al | 125 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 81 | ‐ | ‐ | 79 |
| Pandya & Ganley. | 11 | 22 | ES | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ |
| Pasic et al | 84 | 244 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 30 | 48 | 63 | ‐ |
| Qvarfordt et al | 30 | 60 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 93 | ‐ | ‐ |
| Raikin et al | ‐ | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 20 | 80 | 87 | ‐ |
| Reneman et al | 119 | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 90 | ‐ |
| Rettig et al | 20 | 21 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 83 | 17 | 25 | 66 |
| Roberts et al | 189 | 189 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 52 | ‐ | ‐ | ‐ |
| Rorabeck et al | 24 | 56 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 83 | ‐ | 83 |
| Rorabeck et al | ‐ | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 92 | ‐ | 64 | ‐ |
| Schepsis et al | 30 | 45 | Open | ‐ | ‐ | ‐ | ‐ | 43 | 47 | 7 | 3 | ‐ | 90 | ‐ | ‐ | ‐ |
| Schepsis et al | 46 | 64 | Open | ‐ | ‐ | ‐ | ‐ | 49 | 23 | 14 | 0 | ‐ | ‐ | ‐ | ‐ | ‐ |
| Sebik & Dogan. | 9 | 9 | ES | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | 100 | ‐ |
| Simpson et al | 82 | 82 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 29 | 46 |
| Singh et al | 17 | 64 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ | ‐ |
| Slimmon et al | 117 | 148 | Open | ‐ | ‐ | ‐ | ‐ | 31 | 18 | 19 | 13 | ‐ | ‐ | ‐ | 42 | ‐ |
| Styf & Korner. | 30 | 30 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 74 | ‐ | 63 | 32 |
| Sudmann. | 40 | 40 | MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 15 | 70 | ‐ | ‐ |
| Takebayashi et al | 12 | 20 | ‐ | ‐ | ‐ | ‐ | ‐ | 33 | 33 | 33 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Thein et al | 54 | 54 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 77.4 | ‐ |
| Turnipseed. | 1396 | 2401 | Open & MI | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 91 | ‐ | ‐ |
| Van den Brand et al | 10 | 20 | MI | PE | 61 (±27) | 30 (±8) | <0.05 | |||||||||
| Van der Wal et al | 10 | 10 | MI | PE | 51 (±15) | 36 (±5) | Sig. | ‐ | ‐ | ‐ | ‐ | ‐ | 100 | ‐ | ‐ | ‐ |
| van Zantvoort et al | 54 | 95 | Open | ‐ | ‐ | ‐ | ‐ | 13 | 20 | 23 | 10 | ‐ | ‐ | ‐ | 30 | ‐ |
| Van Zoest et al | ‐ | ‐ | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 19 | ‐ | ‐ | 52 | ‐ | ‐ | ‐ |
| Verleisdonk et al | 100 | 100 | MI |
| ‐ | ‐ | ‐ | ‐ | ‐ | 83 | ‐ | ‐ | ‐ | |||
| Rest | 17 (3‐23) | 15 (4‐29) | >0.05 | |||||||||||||
| PE | 62 (30‐103) | 22 (11‐29 | <0.05 | |||||||||||||
| 5‐min PE | 37 (21‐55) | 16 (7‐28) | <0.05 | |||||||||||||
| Verleisdonk et al | 151 | 151 | MI | Rest | 22 (‐) | 14 (‐) | <0.05 | ‐ | ‐ | ‐ | ‐ | ‐ | 76 | ‐ | ‐ | 76 |
| DE | 58 (‐) | 25.4 (‐) | <0.01 | |||||||||||||
| 5‐min PE | 34 (‐) | 25.2 (‐) | <0.05 | |||||||||||||
| Waterman et al | 754 | 1794 | Open | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 72 |
| Winkes et al | ‐ | ‐ | Open | ‐ | ‐ | ‐ | ‐ | 17 | 31 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Winkes et al | 64 | 64 | Open | ‐ | ‐ | ‐ | ‐ | 23 | 31 | 9 | 8 | ‐ | 76 | ‐ | 29 | ‐ |
| Wittstein et al | 14 | 30 | ES | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 89 | ‐ |
Abbreviations: ‐, information not available; DE, during exercise; ES, endoscopic; ICP, intracompartmental pressure; MI, minimally invasive; PE, post‐exercise.
Comparing conservative and surgical interventions in CECS
| Study | Conservative | Surgical | ICP in mm Hg | Satisfaction (in %) | Return to activity (in%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measurement | Conservative | Surgical | Overall Difference (p‐value) | Conservative | Surgical | Difference (p‐value) | Conservative | Surgical | Overall Difference (p‐value) | ||||||||||
| Patients (n) | Legs (n) | Compartments (n) | Before intervention µ (±SD) | After intervention µ (±SD) | Before intervention µ (±SD) | After intervention µ (±SD) | Satisfied/ improved | Very satisfied/ symptom free | Satisfied/ improved | Very satisfied/ symptom free | Previous level | Full activity | Previous level | Full activity | |||||
| Ali et al | 4 | 24 | 24 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 0 | ‐ | ‐ | 100 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Fronek et al | 5 | 20 | 40 |
Resting PE 1‐min PE 5‐min PE |
17.14(±9.05) 57.0 (±22.4) 42.3 (±21.0) 34.3 (±22.3) | ‐ |
18.5 (±7.94) 55.7(±33.25) 37.4 (±14.3) 27.8 (±9.61) |
9.2 (±0.98) 12.7(±2.49) 10 (±0) 9.8 (±2.23) | ‐ | 20 | ‐ | ‐ | 94 | ‐ | 0 | ‐ | 94 | ‐ | ‐ |
| Packer et al | 27 | 125 | ‐ |
Rest PE |
6.30 (±2.92) 26.67(±11.26) | ‐ |
6.60 (±3.23) 40.44(±9.60) | ‐ |
NS <0.001 | 56 | ‐ | 81 | ‐ | 0.011 | ‐ | 30 | ‐ | 79 | <0.001 |
| Thein et al | 12 | 54 | 54 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 25 | ‐ | 77.4 | ‐ | 0.001 |
| Van der Wal et al | 12 | 10 | 10 | PE | 58 (±15) | 51 (±15) | 51 (±15) | 36 (±5) | ‐ | 0 | ‐ | 100 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Van Zoest et al | 19 | ‐ | ‐ |
Rest PE 1‐min PE 5‐min PE |
14.5 (‐) 15.5 (‐) 13.5 (‐) 12 (‐) |
‐ ‐ ‐ ‐ |
22 (‐) 34.5 (‐) 31.5 (‐) 29.5 (‐) |
‐ ‐ ‐ ‐ |
NS <0.05 <0.05 <0.05 | 84 | ‐ | 52 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ |
| Verleisdonk et al | 3 | 100 | 100 |
| ‐ | 0 | ‐ | 83 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ||||
|
Rest PE 5‐min PE |
‐ ‐ ‐ |
‐ ‐ ‐ |
17 (3‐23) 62 (30‐103) 37 (21‐55) |
15 (4‐29) 22 (11‐29) 16 (7‐28) |
‐ ‐ ‐ | ||||||||||||||
Abbreviations: ‐, information not available; ICP, intracompartmental pressure; NS, non‐significant; PE, post‐exercise.
FIGURE 2Proposed outline for a standardized Patient Reported Outcome Measurement in patients with CECS
|
In studies with civilian patients, usually one or a combination of the three Pedowitz
pre‐exercise pressure ≥ 15 mm Hg one minute post‐exercise pressure of ≥ 30 mm Hg five minute post‐exercise pressure ≥ 20 mm Hg Yet, in service members the value most commonly referred to is the one minute after exercise measurement, with a cutoff value ≥ 35 mm Hg. |